DS
DCM Shriram Fine Chemicals Ltd (DSFCL)
₹24.20
Mkt cap
₹228 Cr
P/E ratio
—
P/B
1.00
Div yield
1.53%
ROE
−0.29%
ROCE
0.74%
EPS (TTM)
—
Book value
₹24
52W range
17–53
Sector
Commodities
Price history
Previous close
DCM Shriram Ltd is a producer of Pharmaceutical Intermediates, particularly in the Anti-Infective segment using Optical Isomer separation as its core competence. [1]
NSE DSFCLBSE 544703
Health check
Cautious
ProfitabilityWeak
GrowthLow
TechnicalsNeutral
52-week range
−53.90% from high₹24
₹17+40.05% from low₹53
Current
₹24.20
Prev close
₹23.70
Day
+2.11%
Price performance
1D
+2.11%
1W
−11.90%
1M
−2.62%
3M
−10.57%
6M
−11.90%
1Y
—
YTD
−49.05%
Financials
Revenue, profit & margin
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 93.35 | 113.09 | 98.62 | 96.90 | 96.95 | 93.08 | 90.78 | 89.97 | |
| YoY Sales growth | +3.86% | -17.69% | -7.95% | -7.15% | |||||
| Expenses | 88.47 | 105.46 | 91.30 | 98.39 | 96.63 | 95.59 | 85.68 | 91.39 | |
| Operating Profit | 4.88 | 7.63 | 7.32 | -1.49 | 0.32 | -2.51 | 5.10 | -1.42 | |
| OPM % | 5.23% | 6.75% | 7.42% | -1.54% | 0.33% | -2.70% | 5.62% | -1.58% | |
| Other Income | 0.99 | 1.01 | 0.94 | 0.68 | 0.81 | 0.74 | 1.06 | 3.39 | |
| Interest | 0.41 | 0.50 | 0.29 | 0.22 | 0.24 | 0.69 | 0.44 | 0.72 | |
| Depreciation | 2.20 | 2.16 | 2.16 | 2.17 | 2.11 | 2.06 | 1.95 | 1.91 | |
| Profit before tax | 3.26 | 5.98 | 5.81 | -3.20 | -1.22 | -4.52 | 3.77 | -0.66 | |
| Tax % | 26.69% | 26.09% | 25.47% | -20.94% | 22.13% | -15.27% | 31.03% | -87.88% | |
| Net Profit | 2.39 | 4.42 | 4.33 | -2.53 | -1.49 | -3.83 | 2.59 | -0.08 | |
| EPS in Rs | 0.24 | 0.44 | 0.43 | -0.25 | -0.17 | -0.44 | 0.30 | -0.01 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Avg earnings-day move +0.44% · closed higher next day 1 of last 1
| Q1FY27 | |
|---|---|
| Broadcast | 14 Aug '26 |
| Earnings day | +0.44% |
| +1 day | +1.43% |
| +5 days | +9.79% |
| +15 days | +2.67% |
| +30 days | +21.32% |
| Filing | XBRL |
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Results analysis
Shareholding
as of Sep 202650.11%Promoter
Promoters50.11%
FIIs0.97%0.06
DIIs11.19%0.18
Public37.73%0.24
Government0.01%0.01
Ownership trend
Peers
8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Pidilite Inds. | ₹1,545.80 | 58.66 | 1,57,446 | 0.74% | 626 | +6.09% | 4,298 | +20.91% | 31.02% |
| Gujarat Fluoroch | ₹4,824.10 | 77.74 | 52,993 | 0.06% | 240 | +35.75% | 1,760 | +45.45% | 9.64% |
| Navin Fluo.Intl. | ₹9,890.00 | 55.39 | 50,750 | 0.15% | 269 | +81.46% | 1,191 | +57.00% | 20.96% |
| Deepak Nitrite | ₹1,594.90 | 20.31 | 21,753 | 0.47% | 398 | +234.99% | 3,076 | +61.75% | 11.37% |
| Aether Industri. | ₹1,632.20 | 85.97 | 21,665 | 0.00% | 68 | +21.62% | 347 | +23.96% | 11.92% |
| Aarti Industries | ₹474.50 | 28.39 | 17,212 | 0.21% | 168 | +100.00% | 3,669 | +74.71% | 6.86% |
| Fine Organic | ₹5,277.00 | 33.59 | 16,179 | 0.21% | 152 | +40.14% | 729 | +22.12% | 21.47% |
| DCM Shriram Fine Chemicals | ₹26.18 | — | 228 | 1.53% | 0 | +96.84% | 90 | −7.15% | 0.74% |
| Median: 95 Co. | ₹334.10 | 25.73 | 832 | 0.26% | 11 | +36.07% | 177 | +28.89% | 14.16% |
Filings
Annual reports1
Credit ratings1
Announcements5
Announcement under Regulation 30 (LODR)-Newspaper Publication 16 Nov - Newspaper publication of Unaudited financial results (Standalone & Consolidated) for the quarter and half year ended September 30, 2026Intimation Regarding Change In The Corporate Office Of The Registrar And Share Transfer Agent (RTA) Of The Company 14 Nov - KFin Technologies’ corporate office address changes effective December 1, 2026.Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association 14 Nov - Board approved Q2 FY27 results, appointed Ashwini Shanker as independent director, and proposed AOA changes.Board Meeting Outcome for Outcome Of Board Meeting For Un-Audited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended September 30, 2026 14 Nov - Board approved Q2 FY26 results, appointed independent director, and proposed AoA changes on November 14, 2026.Unaudited Financial Results For Quarter And Half Year Ended 30.09.2026 14 Nov - Board approved Q2 FY26 results, appointed independent director Ashwini Shanker, and proposed AOA alteration on Nov 14, 2026.






